We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In response to a recent Class I recall, a House committee is requesting information from the FDA on its regulation of heart-device components, particularly defibrillator leads.